Free Trial

American Century Companies Inc. Makes New $918,000 Investment in EverQuote, Inc. $EVER

EverQuote logo with Finance background

Key Points

  • American Century Companies Inc. acquired 35,040 shares of EverQuote, Inc., valued at approximately $918,000, representing 0.10% of the company's stock.
  • Needham & Company LLC has reissued a "buy" rating for EverQuote with a target price of $38.00, while the stock has an average target price of $32.40.
  • EverQuote reported $0.39 earnings per share for the last quarter, surpassing analysts' expectations of $0.35, with a 33.7% year-over-year revenue increase.
  • MarketBeat previews the top five stocks to own by October 1st.

American Century Companies Inc. purchased a new stake in shares of EverQuote, Inc. (NASDAQ:EVER - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 35,040 shares of the company's stock, valued at approximately $918,000. American Century Companies Inc. owned approximately 0.10% of EverQuote at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in EVER. FNY Investment Advisers LLC bought a new position in shares of EverQuote during the 1st quarter valued at approximately $157,000. Arizona State Retirement System bought a new position in EverQuote during the first quarter valued at $202,000. Linden Thomas Advisory Services LLC purchased a new position in shares of EverQuote in the 1st quarter worth $216,000. Cornerstone Investment Partners LLC bought a new stake in shares of EverQuote in the 1st quarter worth about $225,000. Finally, GAMMA Investing LLC raised its position in shares of EverQuote by 3,600.0% during the 1st quarter. GAMMA Investing LLC now owns 8,695 shares of the company's stock valued at $228,000 after buying an additional 8,460 shares in the last quarter. Institutional investors own 91.54% of the company's stock.

Insider Buying and Selling

In other news, CTO David Brainard sold 1,291 shares of the stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $23.50, for a total transaction of $30,338.50. Following the transaction, the chief technology officer directly owned 126,220 shares in the company, valued at approximately $2,966,170. This trade represents a 1.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director John L. Shields sold 2,000 shares of the business's stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $24.00, for a total transaction of $48,000.00. Following the completion of the transaction, the director directly owned 29,219 shares of the company's stock, valued at $701,256. This trade represents a 6.41% decrease in their position. The disclosure for this sale can be found here. Insiders sold 959,250 shares of company stock valued at $22,420,509 over the last quarter. 25.52% of the stock is owned by company insiders.

Analysts Set New Price Targets

Separately, Needham & Company LLC reaffirmed a "buy" rating and set a $38.00 price objective on shares of EverQuote in a research note on Tuesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating and four have assigned a Buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and an average price target of $32.40.

Check Out Our Latest Stock Report on EVER

EverQuote Price Performance

Shares of NASDAQ:EVER traded down $0.25 during trading on Wednesday, reaching $24.07. 21,827 shares of the company were exchanged, compared to its average volume of 537,429. The firm has a market capitalization of $878.69 million, a PE ratio of 19.48 and a beta of 0.54. The business's fifty day simple moving average is $24.14 and its 200-day simple moving average is $24.32. EverQuote, Inc. has a 12-month low of $16.63 and a 12-month high of $30.03.

EverQuote (NASDAQ:EVER - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The company reported $0.39 EPS for the quarter, topping the consensus estimate of $0.35 by $0.04. The company had revenue of $156.63 million for the quarter, compared to the consensus estimate of $157.19 million. EverQuote had a return on equity of 36.90% and a net margin of 7.57%.EverQuote's quarterly revenue was up 33.7% on a year-over-year basis. During the same period last year, the business posted $0.17 EPS. EverQuote has set its Q3 2025 guidance at EPS. On average, sell-side analysts anticipate that EverQuote, Inc. will post 0.72 EPS for the current fiscal year.

EverQuote Profile

(Free Report)

EverQuote, Inc operates an online marketplace for insurance shopping in the United States. The company offers auto, home and renters, and life insurance. The company serves carriers and agents, as well as indirect distributors. The company was formerly known as AdHarmonics, Inc, and changed its name to EverQuote, Inc in November 2014.

See Also

Institutional Ownership by Quarter for EverQuote (NASDAQ:EVER)

Should You Invest $1,000 in EverQuote Right Now?

Before you consider EverQuote, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EverQuote wasn't on the list.

While EverQuote currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.